What is the Luminous Pro Series?

The Luminous Pro Series is a CE-labeled Class I medical device that uses patented red LED technology to illuminate breast tissue, helping you build a personal visual reference of your breast health at home — between clinical visits. It is an adjunct tool, not a diagnostic device.

Does it replace my clinical screenings or doctor visits?

No. The Luminous Pro Series is designed to complement your existing care — not replace it. Regular clinical exams, physician visits, and any screenings your doctor recommends remain essential.

Is red LED light technology safe?
Yes. Red LED light is non-invasive, non-toxic, and radiation-free. There are no known side effects from use.

How often can I use it?
As often as you like. Regular use is actually encouraged — the more consistently you use it, the stronger your personal visual baseline becomes, making it easier to notice if something looks different over time.

Does lighting affect how well it works?
Yes. The device works best in a completely dark room. Ambient light reduces the visibility of the illumination significantly. A bathroom with the lights off is ideal.

What should I do if I notice something that looks different?
Contact your healthcare provider. The Luminous Pro Series helps you observe — your doctor interprets. Any new or unusual visual change is worth a conversation with your physician.

Can I share the device with family members?
Yes. The device can be shared with other adult members of your household.

What is the Luminous Advocacy Project?
The Luminous Advocacy Project is a separate 501(c)(3) nonprofit organization focused on education and research around breast health awareness and red LED light technology. It operates independently from Luminous Global Tech LLC, which develops and markets the Luminous Pro Series.

DISCLAIMER (locked): Luminous Pro Series is not a diagnostic device. It is intended as an adjunct tool for breast health screening alongside clinical or self-examinations — not a replacement for regular screenings or physician visits. While abnormalities may appear as dark shadowed areas, 9 out of 10 tumors are non-cancerous. Any new or unusual breast change should always be evaluated by a healthcare professional.